A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Erlotinib

Need help?
media.product.imagealternatetextformat.details

Erlotinib Impurity 27

N° de SZ CAT: SZ-E018044
Número CAS
183322-16-9
Mol.F.
C15H22O6
Peso Molecular
298.3
Status de Fatura
In Stock

Nome Químico: 3,4-Bis(2-Methoxyethoxy)benzoic Acid Ethyl Ester ; Ethyl 3,4-bis(2-Methoxyethoxy)benzoate

Shipping Temperature:

HSN Code: 38229010

Country of Origin: India

Sorrisos: COCCOC1=C(OCCOC)C=CC(C(OCC)=O)=C1

Erlotinib Impurity 27 is chemically 3,4-Bis(2-Methoxyethoxy)benzoic Acid Ethyl Ester ; Ethyl 3,4-bis(2-Methoxyethoxy)benzoate. Erlotinib Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

🔍

Search by Keywords

Buy 183322-16-9 Purchase 183322-16-9 Order 183322-16-9 Enquire 183322-16-9 Price of 183322-16-9 183322-16-9 Supplier 183322-16-9 Manufacturer 183322-16-9 Exporter Buy high quality Erlotinib Impurity 27 Purchase Erlotinib Impurity 27 Erlotinib Impurity 27 suppliers Erlotinib Impurity 27 manufacturers Erlotinib Impurity 27 price Erlotinib Impurity 27 exporter Order Erlotinib Impurity 27 Enquire Erlotinib Impurity 27 Erlotinib Impurity 27 cost Erlotinib Impurity 27 Supplier Erlotinib Impurity 27 Distributor
ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

,